Impulse oscillometry and spirometry measurements relative to personal best values at the time of acute exacerbations of cystic fibrosis in adults.
acute exacerbation
cystic fibrosis
oscillometry
respiratory function tests
spirometry
Journal
Clinical physiology and functional imaging
ISSN: 1475-097X
Titre abrégé: Clin Physiol Funct Imaging
Pays: England
ID NLM: 101137604
Informations de publication
Date de publication:
Jan 2021
Jan 2021
Historique:
received:
02
06
2020
revised:
22
09
2020
accepted:
25
09
2020
pubmed:
4
10
2020
medline:
2
10
2021
entrez:
3
10
2020
Statut:
ppublish
Résumé
Diagnosis of acute exacerbation (AE) of cystic fibrosis (CF) must be precise because both under- and over-prescription of antibiotics may be detrimental. How lung function tests contribute to diagnose AE is unclear. We aimed to describe variation of spirometry and oscillometry measurements, at Stable state and at AE in adults with CF. Patients were included in a retrospective single-centre study when both spirometry (FEV1, FVC) and oscillometry (X5, R5, R5-R20 and AX) data were available for at least one Stable and one AE visit between December 2016 and July 2019. For each visit, we calculated variation (Δ) in spirometry and oscillometry indices in comparison with personal best values. Measurements were expressed as % of predicted values and Z-scores when applicable. Areas under ROC curves (AUC) were computed. Forty-two patients (28 ± 9 years, FEV1 64 ± 21%) were included; 80 AE and 104 Stable visits were analysed. FEV1 (L, %pred and Z-score) and FVC (%pred and Z-score) varied significantly between AE and Stable visits (p < .05), although differences were small (80 ml/2.7%pred for FEV1). Among oscillometry indices, X5 (kPa.s.L Performance of both spirometry and oscillometry to discriminate AE from Stable state was poor. Variation of oscillometry indices (X5, R5-R20, AX) may be helpful when spirometry is unreliable or uncomfortable.
Sections du résumé
BACKGROUND
BACKGROUND
Diagnosis of acute exacerbation (AE) of cystic fibrosis (CF) must be precise because both under- and over-prescription of antibiotics may be detrimental. How lung function tests contribute to diagnose AE is unclear. We aimed to describe variation of spirometry and oscillometry measurements, at Stable state and at AE in adults with CF.
METHODS
METHODS
Patients were included in a retrospective single-centre study when both spirometry (FEV1, FVC) and oscillometry (X5, R5, R5-R20 and AX) data were available for at least one Stable and one AE visit between December 2016 and July 2019. For each visit, we calculated variation (Δ) in spirometry and oscillometry indices in comparison with personal best values. Measurements were expressed as % of predicted values and Z-scores when applicable. Areas under ROC curves (AUC) were computed.
RESULTS
RESULTS
Forty-two patients (28 ± 9 years, FEV1 64 ± 21%) were included; 80 AE and 104 Stable visits were analysed. FEV1 (L, %pred and Z-score) and FVC (%pred and Z-score) varied significantly between AE and Stable visits (p < .05), although differences were small (80 ml/2.7%pred for FEV1). Among oscillometry indices, X5 (kPa.s.L
CONCLUSIONS
CONCLUSIONS
Performance of both spirometry and oscillometry to discriminate AE from Stable state was poor. Variation of oscillometry indices (X5, R5-R20, AX) may be helpful when spirometry is unreliable or uncomfortable.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
76-84Informations de copyright
© 2020 Scandinavian Society of Clinical Physiology and Nuclear Medicine. Published by John Wiley & Sons Ltd.
Références
Bickel, S., Popler, J., Lesnick, B., & Eid, N. (2014). Impulse oscillometry: Interpretation and practical applications. Chest, 146(3), 841-847. https://doi.org/10.1378/chest.13-1875
Casier, A., Goubert, L., Vervoort, T., Theunis, M., Huse, D., De Baets, F., Matthys, D., & Crombez, G. (2013). Spirometry-related pain and distress in adolescents and young adults with cystic fibrosis: The role of acceptance. Pain Research & Management: The Journal of the Canadian Pain Society, 18(6), 286-292. https://doi.org/10.1155/2013/276923
Castellani, C., Duff, A. J. A., Bell, S. C., Heijerman, H. G. M., Munck, A., Ratjen, F., Sermet-Gaudelus, I., Southern, K. W., Barben, J., Flume, P. A., Hodková, P., Kashirskaya, N., Kirszenbaum, M. N., Madge, S., Oxley, H., Plant, B., Schwarzenberg, S. J., Smyth, A. R., Taccetti, G., … Drevinek, P. (2018). ECFS Best Practice Guidelines: The 2018 Revision. Journal of Cystic Fibrosis: Official Journal of the European Cystic Fibrosis Society, 17(2), 153-178. https://doi.org/10.1016/j.jcf.2018.02.006
Contoli, M., Bousquet, J., Fabbri, L. M., Magnussen, H., Rabe, K. F., Siafakas, N. M., Hamid, Q., & Kraft, M. (2010). The small airways and distal lung compartment in asthma and COPD: A time for reappraisal. Allergy, 65(2), 141-151. https://doi.org/10.1111/j.1398-9995.2009.02242.x
Cooper, P. J., Robertson, C. F., Hudson, I. L., & Phelan, P. D. (1990). Variability of pulmonary function tests in cystic fibrosis. Pediatric Pulmonology, 8(1), 16-22. https://doi.org/10.1002/ppul.1950080107
de Boer, K., Vandemheen, K. L., Tullis, E., Doucette, S., Fergusson, D., Freitag, A., Paterson, N., Jackson, M., Lougheed, M. D., Kumar, V., & Aaron, S. D. (2011). Exacerbation frequency and clinical outcomes in adult patients with cystic fibrosis. Thorax, 66(8), 680-685. https://doi.org/10.1136/thx.2011.161117
Elborn, J. S. (2016). Cystic fibrosis. Lancet (London, England), 388(10059), 2519-2531. https://doi.org/10.1016/S0140-6736(16)00576-6
French CF Registry (2017). French CF Registry - Annual Data Report 2017 [Internet]. Vaincre La Mucoviscidose and French Institute for Demographic Studies (Ined), Paris May 2019. Retrieved from https://www.vaincrelamuco.org/sites/default/files/french_cf_registry_2017_annual_data_report.Pdf
Gangell, C. L., Horak, F., Patterson, H. J., Sly, P. D., Stick, S. M., & Hall, G. L. (2007). Respiratory impedance in children with cystic fibrosis using forced oscillations in clinic. European Respiratory Journal, 30(5), 892-897. https://doi.org/10.1183/09031936.00003407
Goksuluk, D., Korkmaz, S., Zararsiz, G., & Karaagaoglu Ergun, A. (2016). EasyROC: An interactive web-tool for ROC curve analysis using R language environment. R Journal, 8(2), 213. https://doi.org/10.32614/RJ-2016-042
Goss, C. H., & Burns, J. L. (2007). Exacerbations in cystic fibrosis. 1: Epidemiology and pathogenesis. Thorax, 62(4), 360-367. https://doi.org/10.1136/thx.2006.060889
Gosselink, R., & Stam, H. (2005). Lung function testing: European respiratory monograph 31. European Respiratory Society Journals. Retrieved from http://qut.eblib.com.au/patron/FullRecord.aspx?p=463205
Graham, B. L., Steenbruggen, I., Miller, M. R., Barjaktarevic, I. Z., Cooper, B. G., Hall, G. L., Hallstrand, T. S., Kaminsky, D. A., McCarthy, K., McCormack, M. C., Oropez, C. E., Rosenfeld, M., Stanojevic, S., Swanney, M. P., & Thompson, B. R. (2019). Standardization of spirometry 2019 update. An Official American Thoracic Society and European Respiratory Society Technical Statement. American Journal of Respiratory and Critical Care Medicine, 200(8), e70-e88. https://doi.org/10.1164/rccm.201908-1590ST
Haruna, A., Oga, T., Muro, S., Ohara, T., Sato, S., Marumo, S., Kinose, D., Terada, K., Nishioka, M., Ogawa, E., Hoshino, Y., Hirai, T., Chin, K., & Mishima, M. (2010). Relationship between peripheral airway function and patient-reported outcomes in COPD: A cross-sectional study. BMC Pulmonary Medicine, 10(1), 10. https://doi.org/10.1186/1471-2466-10-10
Haute Autorité de Santé. Protocole National de Diagnostic et de Soins (PNDS) Mucoviscidose. Lyon: HAS; Juillet 2017. Retrieved from https://www.has-sante.fr/portail/upload/docs/application/pdf/2017-09/pnds_2017_vf1.pdf
Hoppe, J. E., Wagner, B. D., Accurso, F. J., Zemanick, E. T., & Sagel, S. D. (2018). Characteristics and outcomes of oral antibiotic treated pulmonary exacerbations in children with cystic fibrosis. Journal of Cystic Fibrosis: Official Journal of the European Cystic Fibrosis Society, 17(6), 760-768. https://doi.org/10.1016/j.jcf.2018.05.015
Johnson, M. K., Birch, M., Carter, R., Kinsella, J., & Stevenson, R. D. (2007). Measurement of physiological recovery from exacerbation of chronic obstructive pulmonary disease using within-breath forced oscillometry. Thorax, 62(4), 299-306. https://doi.org/10.1136/thx.2006.061044
Kalchiem-Dekel, O. R., & Hines, S. E. (2018). Forty years of reference values for respiratory system impedance in adults: 1977-2017. Respiratory Medicine, 136, 37-47. https://doi.org/10.1016/j.rmed.2018.01.015
Kamada, T., Kaneko, M., & Tomioka, H. (2017). Impact of exacerbations on respiratory system impedance measured by a forced oscillation technique in COPD: A prospective observational study. International Journal of Chronic Obstructive Pulmonary Disease, 12, 509-516. https://doi.org/10.2147/COPD.S124828
Kerem, E., Reisman, J., Corey, M., Canny, G. J., & Levison, H. (1992). Prediction of mortality in patients with cystic fibrosis. New England Journal of Medicine, 326(18), 1187-1191. https://doi.org/10.1056/NEJM199204303261804
King, G. G., Bates, J., Berger, K. I., Calverley, P., de Melo, P. L., Dellacà, R. L., Farré, R., Hall, G. L., Ioan, I., Irvin, C. G., Kaczka, D. W., Kaminsky, D. A., Kurosawa, H., Lombardi, E., Maksym, G. N., Marchal, F., Oppenheimer, B. W., Simpson, S. J., Thamrin, C., … Oostveen, E. (2020). Technical standards for respiratory oscillometry. European Respiratory Journal, 55(2), https://doi.org/10.1183/13993003.00753-2019
Lacerda, L. S., Lopes, A. J., Carvalho, A. R. S., Guimarães, A. R. M., Firmida, M. C., Castro, M. C. S., Mogami, R., & Melo, P. L. (2018). The role of multidetector computed tomography and the forced oscillation technique in assessing lung damage in adults with cystic fibrosis. Respiratory Care, 63(4), 430-440. https://doi.org/10.4187/respcare.05815
Lee, S.-Y., Bussell, L., Chapman, S., Hopkins, E., & Morton, J. (2019). Adult cystic fibrosis (CF) patients prefer to perform impulse oscillometry (IOS) in comparison to spirometry. European Respiratory Journal, 54(suppl 63), PA336. https://doi.org/10.1183/13993003.congress-2019.PA336
Lee, S.-Y., Morton, J., Chapman, S., Hopkins, E., Holmes-Liew, C.-L., & Bussell, L. (2019). Is impulse oscillometry (IOS) better than spirometry for monitoring treatment outcomes in adult cystic fibrosis (CF) pulmonary exacerbations? A pilot study. European Respiratory Journal, 54(suppl 63), https://doi.org/10.1183/13993003.congress-2019.PA335
Lima, A. N., Faria, A. C. D., Lopes, A. J., Jansen, J. M., & Melo, P. L. (2015). Forced oscillations and respiratory system modeling in adults with cystic fibrosis. BioMedical Engineering OnLine, 14(1), https://doi.org/10.1186/s12938-015-0007-7
McCourt, F., O’Neill, B., Logan, I., Abbott, J., Plant, B., McCrum-Gardner, E., Stephanie McKeown, J., Elborn, S., & Bradley, J. M. (2015). Indicators of pulmonary exacerbation in cystic fibrosis: A Delphi survey of patients and health professionals. Journal of Cystic Fibrosis: Official Journal of the European Cystic Fibrosis Society, 14(1), 90-96. https://doi.org/10.1016/j.jcf.2014.06.007
Nixon, G. M., Armstrong, D. S., Carzino, R., Carlin, J. B., Olinsky, A., Robertson, C. F., & Grimwood, K. (2001). Clinical outcome after early Pseudomonas aeruginosa infection in cystic fibrosis. Journal of Pediatrics, 138(5), 699-704. https://doi.org/10.1067/mpd.2001.112897
Oostveen, E., MacLeod, D., Lorino, H., Farré, R., Hantos, Z., Desager, K., Marchal, F., & ERS Task Force on Respiratory Impedance Measurements (2003). The forced oscillation technique in clinical practice: Methodology, recommendations and future developments. European Respiratory Journal, 22(6), 1026-1041. https://doi.org/10.1183/09031936.03.00089403
Quanjer, P. H., Stanojevic, S., Cole, T. J., Baur, X., Hall, G. L., Culver, B. H., Enright, P. L., Hankinson, J. L., Ip, M. S. M., Zheng, J., & Stocks, J. (2012). Multi-ethnic reference values for spirometry for the 3-95-Yr age range: The global lung function 2012 equations. European Respiratory Journal, 40(6), 1324-1343. https://doi.org/10.1183/09031936.00080312
Ren, C. L., Brucker, J. L., Rovitelli, A. K., & Bordeaux, K. A. (2006). Changes in lung function measured by spirometry and the forced oscillation technique in cystic fibrosis patients undergoing treatment for respiratory tract exacerbation. Pediatric Pulmonology, 41(4), 345-349. https://doi.org/10.1002/ppul.20390
Sakarya, A., Uyan, Z. S., Baydemir, C., Anık, Y., Erdem, E., Gokdemir, Y., Karadag, B., Karakoc, F., & Ersu, R. (2016). Evaluation of children with cystic fibrosis by impulse oscillometry when stable and at exacerbation. Pediatric Pulmonology, 51(11), 1151-1158. https://doi.org/10.1002/ppul.23449
Sanders, D. B., Bittner, R. C. L., Rosenfeld, M., Redding, G. J., & Goss, C. H. (2011). Pulmonary exacerbations are associated with subsequent FEV1 decline in both adults and children with cystic fibrosis. Pediatric Pulmonology, 46(4), 393-400. https://doi.org/10.1002/ppul.21374
Sanders, D. B., Ostrenga, J. S., Rosenfeld, M., Fink, A. K., Schechter, M. S., Sawicki, G. S., Flume, P. A., & Morgan, W. J. (2019). Predictors of pulmonary exacerbation treatment in cystic fibrosis. Journal of Cystic Fibrosis: Official Journal of the European Cystic Fibrosis Society, 19(3), 407-414. https://doi.org/10.1016/j.jcf.2019.06.008
Savushkina, O., Cherniak, A., Kryukov, E., Zaytsev, A., & Nekludova, G. (2019). Impulse oscillometry in chronic obstructive pulmonary disease. European Respiratory Journal, 54(suppl 63). https://doi.org/10.1183/13993003.congress-2019.PA1114
Schulze, J., Biedebach, S., Christmann, M., Herrmann, E., Voss, S., & Zielen, S. (2016). Impulse oscillometry as a predictor of asthma exacerbations in young children. Respiration; International Review of Thoracic Diseases, 91(2), 107-114. https://doi.org/10.1159/000442448
Stenbit, A. E., & Flume, P. A. (2011). Pulmonary exacerbations in cystic fibrosis. Current Opinion in Pulmonary Medicine, 17(6), 442-447. https://doi.org/10.1097/MCP.0b013e32834b8c04
Wagener, J. S., VanDevanter, D. R., Konstan, M. W., Pasta, D. J., Millar, S. J., & Morgan, W. J. (2020). Lung function changes before and after pulmonary exacerbation antimicrobial treatment in cystic fibrosis. Pediatric Pulmonology, 55(3), 828-834. https://doi.org/10.1002/ppul.24577
Wagener, J. S., Williams, M. J., Millar, S. J., Morgan, W. J., Pasta, D. J., & Konstan, M. W. (2018). Pulmonary exacerbations and acute declines in lung function in patients with cystic fibrosis. Journal of Cystic Fibrosis: Official Journal of the European Cystic Fibrosis Society, 17(4), 496-502. https://doi.org/10.1016/j.jcf.2018.02.003
Wainwright, C. E., Stuart Elborn, J., Ramsey, B. W., Marigowda, G., Huang, X., Cipolli, M., Colombo, C., Davies, J. C., De Boeck, K., Flume, P. A., Konstan, M. W., McColley, S. A., McCoy, K., McKone, E. F., Munck, A., Ratjen, F., Rowe, S. M., Waltz, D., & Boyle, M. P., … TRANSPORT Study Group (2015). Lumacaftor-Ivacaftor in patients with cystic fibrosis homozygous for Phe508del CFTR. New England Journal of Medicine, 373(3), 220-231. https://doi.org/10.1056/NEJMoa1409547
Waters, V., Stanojevic, S., Atenafu, E. G., Annie, L. U., Yau, Y., Tullis, E., & Ratjen, F. (2012). Effect of pulmonary exacerbations on long-term lung function decline in cystic fibrosis. European Respiratory Journal, 40(1), 61-66. https://doi.org/10.1183/09031936.00159111
Yamagami, H., Tanaka, A., Kishino, Y., Mikuni, H., Kawahara, T., Ohta, S., Yamamoto, M., Suzuki, S., Ohnishi, T., & Sagara, H. (2018). Association between respiratory impedance measured by forced oscillation technique and exacerbations in patients with COPD. International Journal of Chronic Obstructive Pulmonary Disease, 13, 79-89. https://doi.org/10.2147/COPD.S146669